ATS View
한국어

Deepnoid KRX:315640KOSDAQ

딥노이드 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h1
Articles, 7 days4
DART filings, 7 days0
Articles tracked4since Sep 11

In Q2 2026, Deepnoid reported revenue of ₩1.3bn, down 64.3% year on year, and an operating loss of ₩3.3bn. Deepnoid (딥노이드) appeared in 4 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 4 articles. The most common catalyst was tech & capacity (1). It was most often mentioned alongside SyntekaBio.

Deepnoid quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩1.3bn-64.3%−₩3.3bn−₩3.2bn
Q1 2026₩357m-62.8%−₩4.0bn−₩3.9bn
Q4 2025 derived₩659m-75.0%−₩3.7bn−₩4.1bn
Q3 2025₩2.2bn-45.2%−₩3.0bn−₩3.1bn
Q2 2025₩3.7bn-5.2%−₩233m−₩33m
Q1 2025₩961m+168.5%−₩3.6bn−₩3.5bn
Q4 2024 derived₩2.6bn+145.9%−₩2.8bn−₩2.5bn
Q3 2024₩4.0bn+706.4%−₩1.8bn−₩1.7bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Deepnoid top stories 2 weeks, by number of outlets

  1. 1
    딥노이드-서울대병원, AI 이중판독 연구 KCR 최우수 초록상
    2 outlets · 2 articlesFirst report Sep 14 08:51 메디파나뉴스
  2. 2
    딥노이드, 의료AI '사후검증' 통했다…서울대병원 연구서 민감도↑
    1 outlets · 1 articlesFirst report Sep 14 08:55 파이낸셜뉴스
  3. 3
    [AI의료]딥노이드, AI 이중판독으로 민감도 향상 및 정확도 유지 확인 外 아크릴·신테카바이오
    1 outlets · 1 articlesFirst report Sep 14 18:19 글로벌경제신문SyntekaBio

Latest Deepnoid news Korean headlines